Related Experiment Videos
Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF
1Department of Anesthesia, University of Helsinki, Finland.
Abstract:
Neuropeptide FF (NPFF) has been found to act as an antiopioid peptide. However, IT NPFF has recently been shown to potentiate the antinociceptive effects of IT morphine and to produce antinociception on its own. The aim of this study was to find out whether pretreatment with NPFF causes a comparable potentiation of dexmedetomidine-induced antinociception. NPFF (0.05-10.0 nmol) produced no antinociceptive effects in the rat tail flick test. NPFF potentiated the antinociceptive effect of IT morphine (7.8 nmol). This potentiation was prevented by IT naltrindole (28 nmol), which did not attenuate the antinociceptive effect of morphine. Dexmedetomidine (1.6-6.4 nmol) produced a dose-dependent antinociceptive effect, which was not potentiated by NPFF. Activation of the endogenous delta-opioid system due to the antiopioid effect of IT NPFF is proposed as an explanation to the reported differential action of NPFF on the mu-opioid and the alpha 2-adrenergic systems.
Insights
Neuropeptide FF (NPFF) does not enhance dexmedetomidine
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Neuropeptide FF (NPFF) is recognized as an antiopioid peptide.
- Recent studies indicate NPFF can potentiate morphine's antinociceptive effects and induce antinociception independently.
- The interaction of NPFF with different pain-modulating systems requires further investigation.
Purpose of the Study:
- To investigate if Neuropeptide FF (NPFF) pretreatment potentiates dexmedetomidine-induced antinociception.
- To explore the differential effects of NPFF on mu-opioid and alpha 2-adrenergic systems.
Main Methods:
- The rat tail flick test was employed to assess antinociception.
- Intrathecal (IT) administration of NPFF, morphine, naltrindole, and dexmedetomidine in varying doses.
- Evaluation of NPFF's effect on morphine- and dexmedetomidine-induced antinociception.
Main Results:
- Intrathecal NPFF alone did not produce antinociceptive effects in the rat tail flick test.
- NPFF significantly potentiated the antinociceptive effect of intrathecal morphine.
- This potentiation by NPFF was blocked by naltrindole, a delta-opioid antagonist, but NPFF did not potentiate dexmedetomidine-induced antinociception.
Conclusions:
- Neuropeptide FF (NPFF) selectively potentiates morphine-induced antinociception, likely via delta-opioid system activation.
- NPFF does not potentiate dexmedetomidine-induced antinociception, suggesting differential interactions with mu-opioid and alpha 2-adrenergic systems.
- The findings highlight the complex role of NPFF in pain modulation and its distinct effects on different analgesic pathways.